REFERENCES

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Glycerol Phenylbutyrate (Ravicti) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Cover of Glycerol Phenylbutyrate (Ravicti)

Glycerol Phenylbutyrate (Ravicti) [Internet].

Show details

Contents

< Prev Next >

REFERENCES

1.: ^PrRavicti™ (glycerol phenylbutyrate): oral liquid, 1.1 g/mL [product monograph]. Dublin: Horizon Pharma Ireland Ltd.; 2016 Mar 16.
2.: Pharmacoeconomic evaluation. In: CDR submission: Ravicti™, glycerol phenylbutyrate, 1.1 g/mL, oral liquid. Company: Horizon Therapeutics Canada [CONFIDENTIAL manufacturer’s submission]. Ottawa (ON): Horizon Therapeutics Canada; 2016 Aug 29.
3.: Kibleur Y, Dobbelaere D, Barth M, Brassier A, Guffon N. Results from a nationwide cohort temporary utilization authorization (ATU) survey of patients in France treated with Pheburane((R)) (sodium phenylbutyrate) taste-masked granules. Paediatr Drugs. 2014 Oct;16(5):407–15. [PMC free article: PMC4168023] [PubMed: 24962711]
4.: Lee B, Diaz GA, Rhead W, Lichter-Konecki U, Feigenbaum A, Berry SA, et al. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder. Genet Med. 2015 Jul;17(7):561–8. [PMC free article: PMC4465427] [PubMed: 25503497]
5.: Shchelochkov OA, Lee BH, Scharschmidt BF, Dickinson KA, Herberich E, Hawkins S, et al. Assessment of barriers to drug adherence in the treatment of urea cycle disorders in North America. Clin Biochem. 2016;47(15):153.
6.: Tanuseputro P, Wodchis WP, Fowler R, Walker P, Bai YQ, Bronskill SE, et al. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada. PLoS ONE. 2015;10(3):e0121759. [PMC free article: PMC4374686] [PubMed: 25811195]

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK476302

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Glycerol Phenylbutyrate (Ravicti) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr. REFERENCES.